Fortress Biotech Inc. (NASDAQ:FBIO) Given $11.00 Average Target Price by Analysts


Fortress Biotech Inc. has received a consensus broker rating score of 1.00 from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.



from Biotech News